Real-life effectiveness and safety of Glecaprevir/Pibrentasvir in HCV infected patients with chronic kidney disease. (February 2019) - Aglitti, A.; Caruso, R.; Calvanese, G.; Di Siervi, P.; Tripodi, M.F.; Masarone, M.; Persico, M.